---
title: "Vaxcyte Insider Sold Shares Worth $450,369, According to a Recent SEC Filing"
date: "2025-02-08 05:09:01"
summary: "Mikhail Eydelman, Senior Vice President, General Counsel &amp; Corporate Secretary, on February 05, 2025, sold 5,000 shares in Vaxcyte  for $450,369. Following the Form 4 filing with the SEC, Eydelman has control over a total of 28,222 common shares of the company, with 28,222 shares held directly. SEC Filing:www.sec.gov/Archives/edgar/data/1649094/000164909425000012/xslF345X05/wk-form4_1738962245.xml"
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Mikhail Eydelman, Senior Vice President, General Counsel & Corporate Secretary, on February 05, 2025, sold 5,000 shares in Vaxcyte for $450,369. Following the Form 4 filing with the SEC, Eydelman has control over a total of 28,222 common shares of the company, with 28,222 shares held directly.

SEC Filing:

[www.sec.gov/Archives/edgar/data/1649094/000164909425000012/xslF345X05/wk-form4\_1738962245.xml](https://www.sec.gov/Archives/edgar/data/1649094/000164909425000012/xslF345X05/wk-form4_1738962245.xml)

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250207:A3313030:0/)
